Articles From: Versar, Inc. Announces $4.3 Million Task Order From U.S. Army Corps Of Engineers to Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences


2013/4/16
SPRINGFIELD, Va.
Sign-up for Versar, Inc. Announces $4.3 Million Task Order From U.S. Army Corps Of Engineers investment picks
2013/2/4
SPRINGFIELD, Va.
Sign-up for Versar, Inc. Announces 2Q FY 2013 Earnings Conference Call investment picks
2013/5/6
SPRINGFIELD, Va.
Sign-up for Versar, Inc. Announces 3Q FY 2013 Earnings Conference Call investment picks
2013/2/26
SPRINGFIELD, Va.
Sign-up for Versar, Inc. Announces Afghanistan Personal Services Contract Growth investment picks
2013/2/13
SPRINGFIELD, Va , Feb 13, 2013 /PRNewswire/ -- Versar, Inc. (NYSE MKT: VSR) announced that the United States Army Corps of Engineers, Middle East District (USACE-MED) has exercised an option year for Versar's ongoing Personal Services and Support contract in Iraq.
Sign-up for Versar, Inc. Announces Iraq Contract Extension investment picks
2013/5/13
Reports 22.7% Revenue Growth SPRINGFIELD, Va.
Sign-up for Versar, Inc. Announces Third Quarter Fiscal Year 2013 Results investment picks
2013/2/19
SPRINGFIELD, Va.
Sign-up for Versar, Inc. Awarded Two New Municipal Stormwater Contracts investment picks
2013/5/15
SPRINGFIELD, Va.
Sign-up for Versar, Inc. To Present At B. Riley & Co. 14th Annual Investor Conference investment picks
2013/3/27
Verso Paper Corp.
Sign-up for Verso Paper Corp. Awards Verso Forest Certification Grant to PalletOne of Maine investment picks
2013/4/30
Verso Paper Corp.
Sign-up for Verso Paper Corp. Reports 2012 Sustainability Progress in “Deep Roots, New Routes” investment picks
2013/5/9
Verso Paper Corp.
Sign-up for Verso Paper Corp. Reports First Quarter 2013 Results investment picks
2013/3/7
Verso Paper Corp.
Sign-up for Verso Paper Corp. Reports Fourth Quarter and Year-End 2012 Results investment picks
2013/2/28
Verso Paper Corp.
Sign-up for Verso Paper Corp. to Present at 2013 Goldman Sachs Paper, Forest Products and Packaging Conference investment picks
2013/2/14
Verso Paper Corp.
Sign-up for Verso Paper Corp. to Present at 2013 J.P. Morgan Global High Yield & Leveraged Finance Conference investment picks
2013/4/11
Verso Paper Corp.
Sign-up for Verso to Report First Quarter Results and Host Conference Call on May 9 investment picks
2013/2/5
Verso Paper Corp.
Sign-up for Verso to Report Fourth Quarter and 2012 Results and Host Conference Call on March 7 investment picks
2013/3/14
Versus Capital Advisors, LLC, a mutual fund manager focused on building and managing multi-manager real estate and alternative investment solutions, announced today the formation of a distribution team dedicated to the RIA channel.
Sign-up for Versus Capital Hires Three Proven Leaders, Establishing a National RIA Distribution Team  investment picks
2013/2/26
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the initiation of a global pivotal Phase 3 development program for fixed-dose combinations of VX-809 (lumacaftor) and ivacaftor in people with cystic fibrosis (CF) who have two copies (homozygous) of the F508del mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene.
Sign-up for Vertex Announces Initiation of Pivotal Phase 3 Program of VX-809 in Combination with Ivacaftor for the Treatment of People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation investment picks
2013/4/24
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new data from an interim analysis of the exploratory global Phase 3b CONCISE study evaluating the potential to shorten total treatment with telaprevir combination therapy to 12 weeks in certain people with genotype 1 chronic hepatitis C virus (HCV) infection who have the IL28B CC genotype.
Sign-up for Vertex Announces New Data that Showed High Viral Cure Rates with a Total of 12 and 24 Weeks of Telaprevir Combination Treatment Among People with Genotype 1 Hepatitis C Who Have the IL28B CC Genotype investment picks
2013/2/27
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentation at the 33rd Annual Cowen Health Care Conference on Tuesday, March 5, 2013 at 8:40 a.m. ET and at the Barclays Global Healthcare Conference on Tuesday, March 12, 2013 at 1:00 p.m. ET.
Sign-up for Vertex Announces Webcasts of its Presentations at Two Investor Conferences investment picks
2013/5/17
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it has called for redemption of its outstanding $400.0 million in aggregate principal amount of 3.35% Convertible Senior Subordinated Notes due 2015, pursuant to the provisional “soft call” redemption right in the indenture governing the 2015 Notes.
Sign-up for Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015 investment picks
2013/5/7
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, today announced its financial results for the quarter ended March 31, 2013.
Sign-up for Vertex Energy Reports a 20% Increase in Gross Profit for First Quarter 2013 Compared to First Quarter 2012 investment picks
2013/3/21
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, today announced its financial results for the full year ended December 31, 2012.
Sign-up for Vertex Energy Reports a 23% Increase in Revenue for Fiscal 2012 Compared to 2011 investment picks
2013/4/25
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced that it will release its financial results for first quarter ended March 31, 2013 on May 7, 2013.
Sign-up for Vertex Energy to Release First Quarter 2013 Financial Results on May 7, 2013 investment picks
2013/5/15
Vertex Energy, Inc. (NASDAQ:VTNR) , an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced that Benjamin Cowart, Chairman and CEO, will participate in the first WasteExpo/Wunderlich Securities Investor Summit on Monday, May 20, 2013 at the Ernest N.
Sign-up for Vertex Energy, Inc. to Participate in the First WasteExpo/Wunderlich Securities Investor Summit on May 20, 2013 investment picks
2013/5/6
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced that Benjamin Cowart, Chairman and CEO, will present at Houlihan Lokey's 8th Annual Global Industrials Conference to be held at The Grand Hyatt, New York on Thursday, May 9, 2013 at 2:30 p.m. (Eastern Time). The presentation will be webcast live and will be available in the Investor Relations section of the Company's website at www.vertexenergy.com .
Sign-up for Vertex Energy, Inc. to Present at the 8th Annual Houlihan Lokey's Global Industrials Conference on May 9, 2013 investment picks
2013/3/13
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced that it will release its financial results for fourth quarter and year ended December 31, 2012 on March 21, 2013.
Sign-up for Vertex Energy, Inc. to Release Year-End 2012 Financial Results on March 21, 2013 investment picks
2013/4/5
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb Company (NYSE: BMY) to conduct Phase 2 studies of once-daily all-oral treatment regimens containing Vertex’s nucleotide analogue hepatitis C virus (HCV) polymerase inhibitor VX-135 and Bristol-Myers Squibb’s NS5A replication complex inhibitor daclatasvir for the treatment of hepatitis C.
Sign-up for Vertex Enters Agreement with Bristol-Myers Squibb for Phase 2 All-Oral Studies of VX-135 in Combination with Daclatasvir for the Treatment of Hepatitis C investment picks
2013/5/9
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentations at the Bank of America Healthcare conference on Tuesday, May 14, 2013 at 3:40 PM PT and at the Sanford Bernstein Strategic Decisions conference on Wednesday, May 29, 2013 at 2:00 PM ET.
Sign-up for Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Versar, Inc. Announces $4.3 Million Task Order From U.S. Army Corps Of Engineers to Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity